Concord Medical Services Holdings Limited (CCM)
NYSE: CCM · Real-Time Price · USD
6.00
+1.02 (20.48%)
Aug 1, 2025, 4:00 PM - Market closed

Company Description

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China.

It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.

Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners.

In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel.

Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment.

Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services.

Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.

Concord Medical Services Holdings Limited
Concord Medical Services Holdings logo
CountryChina
Founded1997
IPO DateDec 11, 2009
IndustryMedical Care Facilities
SectorHealthcare
Employees595
CEOJianyu Yang

Contact Details

Address:
East Zone, Hanwei Plaza, Room A1-A5, 26th Floor
Beijing, 100020
China
Phone86 10 5903 6688
Websiteconcordmedical.com

Stock Details

Ticker SymbolCCM
ExchangeNYSE
Fiscal YearJanuary - December
Reporting CurrencyCNY
CIK Code0001472072
CUSIP Number206277105
ISIN NumberUS2062771058
SIC Code8011

Key Executives

NamePosition
Dr. Jianyu YangChairman and Chief Executive Officer
Wei JiangChief Financial Officer
Boxun ZhangChief Strategy Officer
Xun LiuFinancial Controller

Latest SEC Filings

DateTypeTitle
Jul 29, 20256-KReport of foreign issuer
Jul 22, 20256-KReport of foreign issuer
Jul 14, 20256-KReport of foreign issuer
Jul 7, 20256-KReport of foreign issuer
Jun 25, 20256-KReport of foreign issuer
Jun 20, 20256-KReport of foreign issuer
Jun 4, 20256-KReport of foreign issuer
May 29, 20256-KReport of foreign issuer
May 29, 20256-KReport of foreign issuer
May 13, 20256-KReport of foreign issuer